Our client is a global biotechnology company at the forefront of advancing therapies for a range of rare and devastating diseases.
Business Challenge
Our client’s contract manufactured supply chain had long E2E lead times of between 18-24 months and was holding significant volumes of inventory. Our client was in the early stages of a new product launch and were anticipating volumes to ramp up considerably in the near term. EFESO were asked to understand and resolve the performance shortfalls in the existing supply chain and ensure the future supply chain is designed to minimize lead time and inventory.
Key challenges navigated whilst delivering the project include:
- The need to coordinate a cross-functional project involving Quality, Manufacturing, and a Contract Development Manufacturing Organisation.
- The time availability of the project team whilst balancing their business-as-usual responsibilities in a hectic new product introduction environment.
- Willingness of the CDMO to collaborate on the biotech-initiated project and embrace recommendations from the project.
Approach
- People – Ensured the ‘why’ of the project and ‘what’s in it for me’ was clear to all parties through our Human Dynamics approach
- Talking with data –Recommendations made based on clear data analysis so taking the emotion out of performance gaps/opportunities
- Mapping key processes – Spent time with the client at an operational level to map and understand existing processes in detail so that tailored solutions can be developed
- Development of win : win solutions for all parties – The project was enabled by senior commitment to work collaboratively. We held cross functional workshops with an open and honest culture of sharing and problem solving
Main Results
- >60% reduction in Lead time identified in Batch Record Process
- >45% Inventory Reduction
- Mitigated $9m Risk of stock obsolescence
